Examining the Efficacy of a Telemedicine-Based Virtual Reality Clinic in Treating Adults with Specific Phobia: Protocol for A Feasibility Randomized Controlled Efficacy Trial (Preprint)

Author:

Schuler Kaitlyn R.ORCID,Ong TritonORCID,Welch Brandon MORCID,Craggs Jason G.ORCID,Bunnell Brian E.ORCID

Abstract

BACKGROUND

Virtual reality (VR) has strong potential to enhance the effectiveness of telemental health care (TMH) by providing accessible, personalized treatment from home. While there is ample research supporting VR for in-person treatment, there is only preliminary data on the efficacy of telemedicine-based VR. Further, the majority of VR applications used in therapy are not designed for mental healthcare. VR has the potential to enhance TMH through innovative technology solutions designed specifically for the enhancement of remotely delivered evidence-based practices. This feasibility randomized controlled efficacy trial aims to fill both of these gaps by piloting a novel telemedicine-based VR application (Doxy.me VR) equipped with animal phobia exposure stimuli.

OBJECTIVE

This is a feasibility randomized controlled efficacy trial comparing exposure therapy via a telemedicine-based VR clinic versus standard TMH to adults with intense fear of dogs, snakes, and/or spiders. The primary objective is to assess the feasibility of a fully-powered trial. The secondary objective is to conduct a preliminary examination of clinical outcomes (e.g., specific phobia symptoms).

METHODS

This single-site trial will enroll a minimum of 30 and maximum of 60 adults with self-reported fear of dogs, snakes, and/or spiders. Potential participants will be recruited through online platforms and posting flyers. All procedures will be partially automated using REDCap forms and surveys, but the baseline assessment of phobia symptoms will be administered by the study therapist.

RESULTS

Feasibility of the proposed trial methodology will be assessed using enrollment, retention, assessment completion, and treatment protocol fidelity benchmarks. Between-group differences in specific phobia, anxiety, and depression symptoms while co-varying for pre-treatment scores, will be conducted using r-ANOVA along with differences in therapeutic alliance and presence. Data obtained from these analyses will inform power analyses for a fully powered efficacy trial.

CONCLUSIONS

This feasibility RCT comparing Doxy.me VR vs. TMH aims to enhance the delivery of evidence-based treatments via telemedicine and reduce barriers to remotely delivered exposure therapy. This feasibility trial will be followed by a fully powered efficacy trial on telemedicine-based VR for animal phobias.

CLINICALTRIAL

This trial was registered on ClinicalTrials.gov [NCT06302868]

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3